- The search for beta-lactamase inhibitors (BLIs) is critical in combating antibiotic resistance. 
- They halt the mechanism of beta-lactamases by chemically mimicking the beta-lactam ring to bind to the enzyme but it stops the catalytic activity of the enzyme. 
- Most have contained the beta-lactam ring as well.
- Clavulanic acid is an example (image below)

How to combat beta-lactam antibiotic resistance?

Bacteria achieve resistance to beta-lactam antibiotics primarily through the production of beta-lactamase enzymes. These enzymes bind to the antibiotic's characteristic beta-lactam ring and hydrolyze it, breaking the ring structure. This inactivation prevents the antibiotic from inhibiting cell wall synthesis, rendering it ineffective.

Grand Valley State University

Google

- They have a characteristic beta-lactam ring that is important in its mechanism of action. 
- These antibiotics inhibit cell wall synthesis in bacteria thus preventing bacterial replication and further bacterial propagation.
- Known antibiotics: Penicillins, cephalosporins, carbapenems
- In recent years, increasing resistance to this type of antibiotic has been a growing concern.

Beta-lactam antibiotics 

- The Acinetobacter derived cephalosporinase (ADC) enzyme is a beta-lactamase 
- ADC-7 has broad antibiotic properties. 
- It is a target for novel beta-lactamase inhibitors (BLIs). 
- Not a currently targeted beta-lactamase for an inhibitor

ADC-7

Powers, R. A., Swanson, H. C., Taracila, M. A., Florek, N. W., Romagnoli, C., Caselli, E., Prati, F., Bonomo, R. A., & Wallar, B. J. (2014). Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii. Biochemistry, 53(48), 7670–7679. https://doi.org/10.1021/bi500887n

Learn Before

Related

Learn After